ATE156828T1 - Phosphinyloxy propanaminium innersalzderivate - Google Patents
Phosphinyloxy propanaminium innersalzderivateInfo
- Publication number
- ATE156828T1 ATE156828T1 AT93810406T AT93810406T ATE156828T1 AT E156828 T1 ATE156828 T1 AT E156828T1 AT 93810406 T AT93810406 T AT 93810406T AT 93810406 T AT93810406 T AT 93810406T AT E156828 T1 ATE156828 T1 AT E156828T1
- Authority
- AT
- Austria
- Prior art keywords
- phosphinyloxy
- propanaminium
- internal salt
- salt derivatives
- thiolysis
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000008878 coupling Effects 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000005859 coupling reaction Methods 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 150000002148 esters Chemical group 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Chemical group 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 238000006177 thiolation reaction Methods 0.000 abstract 1
- 238000007079 thiolysis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
- C07F9/165—Esters of thiophosphoric acids
- C07F9/1651—Esters of thiophosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/113—Esters of phosphoric acids with unsaturated acyclic alcohols
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89721092A | 1992-06-11 | 1992-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE156828T1 true ATE156828T1 (de) | 1997-08-15 |
Family
ID=25407534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93810406T ATE156828T1 (de) | 1992-06-11 | 1993-06-07 | Phosphinyloxy propanaminium innersalzderivate |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0574355B1 (de) |
| JP (1) | JPH0673077A (de) |
| KR (1) | KR940005647A (de) |
| CN (1) | CN1039326C (de) |
| AT (1) | ATE156828T1 (de) |
| AU (1) | AU667537B2 (de) |
| CA (1) | CA2098133A1 (de) |
| CZ (1) | CZ108393A3 (de) |
| DE (1) | DE69313029T2 (de) |
| DK (1) | DK0574355T3 (de) |
| ES (1) | ES2105194T3 (de) |
| FI (1) | FI932662A (de) |
| GR (1) | GR3024684T3 (de) |
| HU (2) | HUT65327A (de) |
| IL (1) | IL105965A (de) |
| MY (1) | MY109005A (de) |
| NO (1) | NO932096L (de) |
| NZ (1) | NZ247840A (de) |
| SG (1) | SG42983A1 (de) |
| SK (1) | SK58893A3 (de) |
| ZA (1) | ZA934157B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1299266B1 (it) * | 1998-05-15 | 2000-02-29 | Sigma Tau Ind Farmaceuti | Inibitori reversibili della carnitina palmitoil trasferasi |
| DE602004029319D1 (de) | 2003-02-18 | 2010-11-11 | Univ Tokai | Verbindung mit phoshorylcholingruppe, dessen polymer und verfahren zu dessen herstellung |
| KR20090034969A (ko) | 2006-08-02 | 2009-04-08 | 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. | 씨피티-억제제로서 4-트라이메틸암모늄-3-아미노부티레이트및 4-트라이메틸포스포늄-3-아미노부티레이트의 유도체 |
| KR20220054351A (ko) | 2019-08-30 | 2022-05-02 | 인스티튜트 오브 주올로지, 차이니즈 아카데미 오브 사이언스 | 대사 질환의 예방을 위해 사용된 조성물 및 조성물의 용도 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0348859A1 (de) * | 1988-07-01 | 1990-01-03 | MAGIS FARMACEUTICI S.p.A. | 1,2-Di-O-acyl glycero(DI)phosphat von L-carnitin und dessen Derivate, ein Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel |
| IT1231751B (it) * | 1989-04-12 | 1991-12-21 | Sigma Tau Ind Farmaceuti | Procedimento per la produzione di r(+) amminocarnitina e s(-) amminocarnitina |
| IT1230141B (it) * | 1989-05-03 | 1991-10-14 | Fidia Spa | Impiego di derivati della fosfatidil carnitina per la preparazione di composizioni farmaceutiche aventi attivita' nella terapia delle patologie dell'uomo associate con un danno neuronale. |
| IT1230142B (it) * | 1989-05-03 | 1991-10-14 | Fidia Spa | Derivati della carnitina, processo per la loro preparazione e impiego in terapia umana |
-
1993
- 1993-05-28 HU HU9301587A patent/HUT65327A/hu unknown
- 1993-06-04 CZ CZ931083A patent/CZ108393A3/cs unknown
- 1993-06-07 ES ES93810406T patent/ES2105194T3/es not_active Expired - Lifetime
- 1993-06-07 SG SG1996001845A patent/SG42983A1/en unknown
- 1993-06-07 DE DE69313029T patent/DE69313029T2/de not_active Expired - Fee Related
- 1993-06-07 DK DK93810406.4T patent/DK0574355T3/da active
- 1993-06-07 AT AT93810406T patent/ATE156828T1/de not_active IP Right Cessation
- 1993-06-07 EP EP93810406A patent/EP0574355B1/de not_active Expired - Lifetime
- 1993-06-08 MY MYPI93001104A patent/MY109005A/en unknown
- 1993-06-09 IL IL105965A patent/IL105965A/xx not_active IP Right Cessation
- 1993-06-09 AU AU40115/93A patent/AU667537B2/en not_active Ceased
- 1993-06-09 NO NO932096A patent/NO932096L/no unknown
- 1993-06-10 FI FI932662A patent/FI932662A/fi unknown
- 1993-06-10 SK SK588-93A patent/SK58893A3/sk unknown
- 1993-06-10 NZ NZ247840A patent/NZ247840A/en unknown
- 1993-06-10 CA CA002098133A patent/CA2098133A1/en not_active Abandoned
- 1993-06-10 KR KR1019930010558A patent/KR940005647A/ko active IP Right Grant
- 1993-06-10 CN CN93108729A patent/CN1039326C/zh not_active Expired - Fee Related
- 1993-06-10 JP JP5163868A patent/JPH0673077A/ja active Pending
- 1993-06-11 ZA ZA934157A patent/ZA934157B/xx unknown
-
1995
- 1995-06-19 HU HU95P/P00248P patent/HU211489A9/hu unknown
-
1997
- 1997-09-10 GR GR970402332T patent/GR3024684T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU667537B2 (en) | 1996-03-28 |
| AU4011593A (en) | 1993-12-16 |
| CA2098133A1 (en) | 1993-12-12 |
| SK58893A3 (en) | 1994-06-08 |
| NO932096D0 (no) | 1993-06-09 |
| HU211489A9 (en) | 1995-11-28 |
| GR3024684T3 (en) | 1997-12-31 |
| EP0574355B1 (de) | 1997-08-13 |
| DK0574355T3 (da) | 1998-01-26 |
| ES2105194T3 (es) | 1997-10-16 |
| EP0574355A1 (de) | 1993-12-15 |
| ZA934157B (en) | 1994-09-05 |
| NZ247840A (en) | 1995-04-27 |
| CN1039326C (zh) | 1998-07-29 |
| HU9301587D0 (en) | 1993-09-28 |
| DE69313029D1 (de) | 1997-09-18 |
| JPH0673077A (ja) | 1994-03-15 |
| MY109005A (en) | 1996-11-30 |
| FI932662A0 (fi) | 1993-06-10 |
| IL105965A0 (en) | 1993-10-20 |
| CZ108393A3 (en) | 1995-02-15 |
| NO932096L (no) | 1993-12-13 |
| KR940005647A (ko) | 1994-03-22 |
| SG42983A1 (en) | 1997-10-17 |
| IL105965A (en) | 1997-03-18 |
| HUT65327A (en) | 1994-05-02 |
| DE69313029T2 (de) | 1998-01-29 |
| FI932662A (fi) | 1993-12-12 |
| CN1086217A (zh) | 1994-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI953968A0 (fi) | Antraniiliset happojohdannaiset | |
| ES2031569T3 (es) | Derivados de acidos quinolinocarboxilicos. | |
| MX9206679A (es) | Nuevo proceso para la preparacion de derivados substituidos de la tiazolidindiona | |
| ATE165600T1 (de) | Diphenylpiperazinderivat und dieses enthaltendes arzneimittel für kreislauforgane | |
| ATE92489T1 (de) | Imid-derivate, ihre herstellung und verwendung. | |
| ATE156828T1 (de) | Phosphinyloxy propanaminium innersalzderivate | |
| EP0270093A3 (de) | Lactamderivate, Verfahren zu deren Herstellung, sie enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung zur Herstellung von aktiven therapeutischen Arzneimitteln | |
| JPS5551041A (en) | Phenyl-fatty acid derivative | |
| ATE236162T1 (de) | Pyrroloazepinderivate | |
| IE800399L (en) | 6-alpha-methoxy-penicillin derivatives. | |
| ATE158585T1 (de) | Substituierte bizyklische oxazol- und thiazol- äther | |
| IE40182L (en) | Aminoethanol derivatives | |
| DE69511689T2 (de) | Phosphonyldipeptide zur bekämpfung von kardiovasvakuläre erkrankungen | |
| DE59309898D1 (de) | 4-oxo-azetidin-2-sulfonsäureamide und ihre salze, verfahren zu deren herstellung und ihre verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |